Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT) Stock Gains On Approval of Reverse Stock Split

June 24, 2022

The biotech sector has attracted a lot of attention from investors over the course of the past years and remains one of the more sought-after sectors. One of the biotech stocks which came into focus in a big way among investors on Thursday was of the clinical-stage biotech firm Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT). Trading Data On Thursday, PVCT stock surged 15% to $0.0609 with more than 280K shares, compared to…


Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT) Stock Falls a Bit After Key Update

February 17, 2022

Although it is true that Provectus Biopharmaceuticals Inc (OTCMKTS:PVCT) did make a significant announcement on Tuesday, it did not come as a much of a boost for its stock. In fact, the stock suffered from a selloff and went down by as much as 5% for the day. Trading Data On Wednesday, PVCT stock fell 4.71% to $0.0667 with more than 508k shares, compared to its average volume of 254k…